Chemical inhibitors of RDH7 can exert their inhibitory effects through various biochemical mechanisms. Retinal, for example, serves as a competitive antagonist by binding to the same site on RDH7 that normally binds retinol, which is RDH7's natural substrate. This binding prevents RDH7 from converting retinol into retinaldehyde, essentially blocking the enzyme's primary function. Similarly, Citral forms a reaction with the alcohol group of retinol, reducing the pool of substrate available for RDH7 to act upon. This reaction alters retinol so that it cannot be recognized and processed by RDH7. Farnesol, by integrating into cellular membranes, can influence the function of membrane-bound enzymes like RDH7. This integration disrupts the normal activity of RDH7, leading to decreased enzymatic action. Bisphenol A also associates with cellular membranes and can disturb the function of membrane-associated enzymes such as RDH7, leading to a reduction in the enzyme's catalytic activity.
Furthermore, Methotrexate indirectly inhibits RDH7 by interfering with the cellular uptake and metabolism of retinol, limiting the availability of the enzyme's substrate. Benzo[a]pyrene forms adducts with retinol, which prevents RDH7 from accessing and processing its substrate. Synthetic derivatives of retinol, such as 4-Hydroxyphenyl retinamide and analogues like Isotretinoin and Tretinoin, can occupy the active site of RDH7, which directly impedes the enzyme's ability to metabolize retinol. N-Ethylmaleimide can modify cysteine residues on RDH7, potentially altering the enzyme's structure and function, leading to inhibition. Oleanolic acid alters membrane fluidity and permeability, which can affect the activity of RDH7. Lastly, Ellagic acid can bind to RDH7, potentially modifying its structure or directly blocking its active site, which results in the inhibition of the enzyme's function. Each of these chemicals, through their distinct interactions with RDH7 or its substrate, can effectively inhibit the enzymatic activity of RDH7.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
all-trans Retinal | 116-31-4 | sc-210778A sc-210778 | 250 mg 1 g | $126.00 $372.00 | 7 | |
Retinal is a direct competitor with RDH7 for retinol, the substrate of RDH7. By binding retinol, it prevents RDH7 from accessing its substrate, thereby inhibiting the enzyme's activity. | ||||||
Citral | 5392-40-5 | sc-252620 | 1 kg | $212.00 | ||
Citral is an aldehyde that can react with the alcohol group of retinol, reducing its availability for RDH7 and consequently inhibiting the enzyme's ability to convert retinol to retinaldehyde. | ||||||
Farnesol | 4602-84-0 | sc-204748 sc-204748A | 50 ml 100 ml | $275.00 $367.00 | 2 | |
Farnesol is a sesquiterpene that can incorporate into the cellular membrane and indirectly affect membrane-associated enzymes like RDH7, leading to the inhibition of the enzyme's activity. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A can integrate into cellular membranes and potentially disrupt membrane-bound enzymes like RDH7, leading to the inhibition of the enzyme's function. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate can lead to a decrease in retinol levels by affecting cellular uptake and metabolism, which would limit the substrate availability for RDH7, thereby inhibiting its activity. | ||||||
Benzo[a]pyrene | 50-32-8 | sc-257130 | 1 g | $439.00 | 4 | |
Benzo[a]pyrene, a polycyclic aromatic hydrocarbon, can form adducts with retinol, thus preventing RDH7 from accessing its substrate and inhibiting the enzyme's function. | ||||||
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
4-Hydroxyphenyl retinamide is a synthetic derivative of retinol which can competitively inhibit RDH7 by occupying the enzyme's active site, preventing the conversion of retinol to retinaldehyde. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $74.00 $118.00 | 8 | |
Isotretinoin, a retinoic acid analogue, can compete with retinol for the active site of RDH7, thereby inhibiting the conversion of retinol to retinaldehyde by the enzyme. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Tretinoin is another retinoic acid analogue that can bind to the active site of RDH7, hindering the enzyme's ability to metabolize retinol into retinaldehyde. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $68.00 $210.00 $780.00 $1880.00 | 19 | |
N-Ethylmaleimide can react with cysteine residues on enzymes, and if RDH7 has accessible cysteine residues on or near its active site, this could result in the inhibition of its activity. | ||||||